Literature DB >> 12173125

High levels of adenovirus DNA in serum correlate with fatal outcome of adenovirus infection in children after allogeneic stem-cell transplantation.

Marco W Schilham1, Eric C Claas, Wouter van Zaane, Bianca Heemskerk, Jaak M Vossen, Arjan C Lankester, Rene E Toes, Marcela Echavarria, Aloys C Kroes, Maarten J van Tol.   

Abstract

An increase in the incidence of adenovirus (AdV) infection leading to death among children who have undergone allogeneic stem-cell transplantation has made it necessary to find new ways to monitor AdV infection. In this retrospective study, levels of AdV DNA in serum samples obtained from 36 transplant recipients with stool cultures positive for AdV were measured by polymerase chain reaction (PCR) semiquantitatively by analyzing serial dilutions of the DNA template. Six (86%) of 7 children who died of AdV infection, compared with only 2 (7%) of 29 other patients, had high serum levels of AdV DNA (detectable by PCR at a > or =100-fold dilution of the DNA template; P<.0001). High serum levels of AdV DNA were reached a mean of 18 days before death (range, 6-29 days). Quantification of adenoviral DNA in serum may prove to be a valuable tool to diagnose and monitor AdV infection and disease in immunocompromised children.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12173125     DOI: 10.1086/341770

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  39 in total

1.  Comparison of in-house real-time quantitative PCR to the Adenovirus R-Gene kit for determination of adenovirus load in clinical samples.

Authors:  Hélène Jeulin; Alexandra Salmon; Pierre Bordigoni; Véronique Venard
Journal:  J Clin Microbiol       Date:  2010-07-14       Impact factor: 5.948

2.  Internally controlled real-time PCR monitoring of adenovirus DNA load in serum or plasma of transplant recipients.

Authors:  Eric C J Claas; Marco W Schilham; Caroline S de Brouwer; Petr Hubacek; Marcela Echavarria; Arjan C Lankester; Maarten J D van Tol; Aloys C M Kroes
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

3.  Typing of human adenoviruses in specimens from immunosuppressed patients by PCR-fragment length analysis and real-time quantitative PCR.

Authors:  Karin Ebner; Margit Rauch; Sandra Preuner; Thomas Lion
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

4.  Adenovirus: current epidemiology and emerging approaches to prevention and treatment.

Authors:  Uriel Sandkovsky; Luciano Vargas; Diana F Florescu
Journal:  Curr Infect Dis Rep       Date:  2014-08       Impact factor: 3.725

5.  Expression of an engineered soluble coxsackievirus and adenovirus receptor by a dimeric AAV9 vector inhibits adenovirus infection in mice.

Authors:  C Röger; T Pozzuto; R Klopfleisch; J Kurreck; S Pinkert; H Fechner
Journal:  Gene Ther       Date:  2015-03-19       Impact factor: 5.250

6.  Molecular detection and quantitative analysis of the entire spectrum of human adenoviruses by a two-reaction real-time PCR assay.

Authors:  K Ebner; M Suda; F Watzinger; T Lion
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

7.  Mouse adenovirus type 1 infection in SCID mice: an experimental model for antiviral therapy of systemic adenovirus infections.

Authors:  L Lenaerts; E Verbeken; E De Clercq; L Naesens
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

8.  Adenovirus viremia and disease: comparison of T cell-depleted and conventional hematopoietic stem cell transplantation recipients from a single institution.

Authors:  Yeon Joo Lee; Dick Chung; Kun Xiao; Esperanza B Papadopoulos; Juliet N Barker; Trudy N Small; Sergio A Giralt; Junting Zheng; Ann A Jakubowski; Genovefa A Papanicolaou
Journal:  Biol Blood Marrow Transplant       Date:  2012-10-22       Impact factor: 5.742

Review 9.  Adenoviruses in immunocompromised hosts.

Authors:  Marcela Echavarría
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

Review 10.  The challenge of respiratory virus infections in hematopoietic cell transplant recipients.

Authors:  Michael Boeckh
Journal:  Br J Haematol       Date:  2008-09-10       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.